Isolated heart transplantation for familial transthyretin (TTR) V122I cardiac amyloidosis

Amyloid

Volumn 21, Issue 2, 2014, Pages 120-123

  Thenappan, Thenappan ^a,c   Fedson, Savitri ^a   Rich, Jonathan ^b   Murks, Catherine ^a   Husain, Aliya ^a   Pogoriler, Jennifer ^a   Anderson, Allen S ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Endomyocardial biopsy; Heart failure; Liver transplantation

Indexed keywords

AMYLOID; AMYLOID PROTEIN; ISOLEUCINE; PREALBUMIN; VALINE;

ADULT; ARTICLE; CASE REPORT; CONGESTIVE CARDIOMYOPATHY; FAMILIAL AMYLOIDOSIS; GENE MUTATION; HEART AMYLOIDOSIS; HEART GRAFT; HEART MUSCLE; HEART TRANSPLANTATION; HUMAN; ISOLATED HEART; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PRIORITY JOURNAL; TREATMENT OUTCOME; AMYLOIDOSIS; CARDIOMYOPATHIES; GENETICS; METABOLISM;

AMYLOID; AMYLOIDOSIS; CARDIOMYOPATHIES; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PREALBUMIN;

EID: 84900542361     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.3109/13506129.2013.853660     Document Type: Article

References (15)

1. Dubrey SW, Hawkins PN, Falk RH. Amyloid diseases of the heart: assessment, diagnosis, and referral. Heart 2011; 97: 75-84.
2. Ruberg FL, Berk JL. Transthyretin (TTR) cardiac amyloidosis. Circulation 2012; 126: 1286-300.
3. Benson MD, Kincaid JC. The molecular biology and clinical features of amyloid neuropathy. Muscle Nerve 2007; 36: 411-23.
4. Jacobson DR, Pastore RD, Yaghoubian R, Kane I, Gallo G, Buck FS, Buxbaum JN. Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans. N Engl J Med 1997; 336: 466-73.
5. Yamashita T, Hamidi Asl K, Yazaki M, Benson MD. A prospective evaluation of the transthyretin Ile122 allele frequency in an African-American population. Amyloid 2005; 12: 127-30.
6. Hamour IM, Lachmann HJ, Goodman HJ, Petrou M, Burke MM, Hawkins PN, Banner NR. Heart transplantation for homozygous familial transthyretin (TTR) V122I cardiac amyloidosis. Am J Transplant 2008; 8: 1056-9.
7. Fuchs U, Zittermann A, Suhr O, Holmgren G, Tenderich G, Minami K, Koerfer R. Heart transplantation in a 68-year-old patient with senile systemic amyloidosis. Am J Transplant 2005; 5: 1159-62.
8. Dungu JN, Anderson LJ, Whelan CJ, Hawkins PN. Cardiac transthyretin amyloidosis. Heart 2012; 98: 1546-54.
9. Dubrey SW, Burke MM, Hawkins PN, Banner NR. Cardiac transplantation for amyloid heart disease: the United Kingdom experience. J Heart Lung Transplant 2004; 23: 1142-53.
10. Te HS, Anderson AS, Millis JM, Jeevanandam V, Jensen DM. Current state of combined heart-liver transplantation in the United States. J Heart Lung Transplant 2008; 27: 753-9.
11. Ammirati E, Marziliano N, Vittori C, Pedrotti P, Bramerio MA, Motta V, Orsini F, et al. The first Caucasian patient with p.Val122Ile mutated-transthyretin cardiac amyloidosis treated with isolated heart transplantation. Amyloid 2012; 19: 113-17.
12. Kapoor P, Thenappan T, Singh E, Kumar S, Greipp PR. Cardiac amyloidosis: a practical approach to diagnosis and management. Am J Med 2011; 124: 1006-15.
13. Rahman JE, Helou EF, Gelzer-Bell R, Thompson RE, Kuo C, Rodriguez ER, Hare JM, et al. Noninvasive diagnosis of biopsyproven cardiac amyloidosis. J Am Coll Cardiol 2004; 43: 410-15.
14. van den Driesen RI, Slaughter RE, Strugnell WE. MR findings in cardiac amyloidosis. AJR Am J Roentgenol 2006; 186: 1682-5.
15. Chen W, Dilsizian V. Molecular imaging of amyloidosis: will the heart be the next target after the brain? Curr Cardiol Rep 2012; 14: 226-33.